These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 18563622)

  • 1. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.
    Hippisley-Cox J; Coupland C
    BMJ; 2005 May; 330(7499):1059-63. PubMed ID: 15879390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for coronary CT angiography to tailor medical therapy beyond preventive guideline-based recommendations: insights from the ROMICAT I trial.
    Pursnani A; Schlett CL; Mayrhofer T; Celeng C; Zakroysky P; Bamberg F; Nagurney JT; Truong QA; Hoffmann U
    J Cardiovasc Comput Tomogr; 2015; 9(3):193-201. PubMed ID: 25846248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missed opportunities for the secondary prevention of cardiovascular disease in Canada.
    Hackam DG; Leiter LA; Yan AT; Yan RT; Mendelsohn A; Tan M; Zavodni L; Chen R; Tsang JL; Kundi A; Lin PJ; Fitchett DH; Langer A; Goodman SG;
    Can J Cardiol; 2007 Dec; 23(14):1124-30. PubMed ID: 18060097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice.
    Williams JB; Delong ER; Peterson ED; Dokholyan RS; Ou FS; Ferguson TB;
    Circulation; 2011 Jan; 123(1):39-45. PubMed ID: 21173357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis.
    Okeke NL; Chin T; Clement M; Chow SC; Hicks CB
    AIDS Care; 2016; 28(4):475-82. PubMed ID: 26479580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensible prescribing for older people.
    Wynne HA
    Clin Med (Lond); 2003; 3(5):409-12. PubMed ID: 14601937
    [No Abstract]   [Full Text] [Related]  

  • 7. Comprehensive coronary artery disease care in a safety-net hospital: results of Get With The Guidelines quality improvement initiative.
    Krantz MJ; Baker WA; Estacio RO; Haynes DK; Mehler PS; Fonarow GC; Long CS
    J Manag Care Pharm; 2007 May; 13(4):319-25. PubMed ID: 17506598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial.
    Edworthy SM; Baptie B; Galvin D; Brant RF; Churchill-Smith T; Manyari D; Belenkie I
    Can J Cardiol; 2007 Nov; 23(13):1066-72. PubMed ID: 17985009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEDIS, beta-blockers, and what more can be done to improve secondary prevention in ACS.
    Curtiss FR
    J Manag Care Pharm; 2008 Apr; 14(3):316-7. PubMed ID: 18439055
    [No Abstract]   [Full Text] [Related]  

  • 10. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
    Sharma KK; Gupta R; Agrawal A; Roy S; Kasliwal A; Bana A; Tongia RK; Deedwania PC
    Vasc Health Risk Manag; 2009; 5():1007-14. PubMed ID: 19997570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals.
    Nguyen T; Nguyen HQ; Widyakusuma NN; Nguyen TH; Pham TT; Taxis K
    BMJ Open; 2018 Jan; 8(1):e018271. PubMed ID: 29326185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological prevention of coronary relapses in Italian clinical practice: a literature review].
    Pedrinelli R; Ciccone M; Novo S; Catapano AL
    G Ital Cardiol (Rome); 2012 Nov; 13(11):734-40. PubMed ID: 23096582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year follow-up of drug utilization for secondary prevention in coronary artery disease.
    Apikoglu Rabus S; Izzettin FV; Sancar M; Karakaya O; Kargin R; Yakut C
    Pharm World Sci; 2008 Dec; 30(6):753-8. PubMed ID: 18563622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.